August 17, 2016 New opioid candidate may help reduce overdoses The main cause of opioid overdose is respiratory suppression, but researchers have identified a compound that mimics commonly used drugs’ painkilling effects and lacks that lethal characteristic.
August 12, 2016 Germany: Prosecutors probe 3 deaths at cancer clinic BERLIN — German prosecutors say they're investigating the operator of a clinic near the Dutch border that offers alternative cancer treatment on suspicion of negligent manslaughter and bodily harm after three people who were treated at the facility died.
August 10, 2016 French government denies hiding drug-related birth defects study PARIS — French health authorities are denying claims they concealed a study on a drug used to treat epilepsy that caused birth defects.
August 10, 2016 FDA approves Heron's therapy for chemotherapy-induced nausea Heron Therapeutics Inc said its injection to prevent chemotherapy-induced nausea and vomiting was approved by the U.S. Food and Drug Administration.
August 10, 2016 Are you contributing to the rise of superbugs? The next time your doctor prescribes— or refuses to prescribe— antibiotics for an illness, you might want to listen and follow directions exactly.
August 9, 2016 Common treatments for skin tags Most people suffer with some sort of embarrassing skin problem at some point in their lifetime. But not all skin issues are easy to identify
August 9, 2016 Future of drug pricing: paying for benefits, not per pill LONDON — Global pressure on health spending is forcing the $1 trillion-a-year pharmaceutical industry to look for new ways to price its products: charging based on how much they improve patients' health, rather than how many pills or vials are sold.
August 8, 2016 Family of 5-year-old California girl 'locked' in her body remain optimistic for cure When she was 2 years old, Magnolia “Maggie” Tesler, had hit all of her developmental milestones, but was starting to lose some of the words she learned in her young life.
August 8, 2016 Novartis asthma pill shows promise in small trial The first new asthma pill in decades has produced promising results in a small clinical trial, potentially paving the way for another treatment option for patients by the end of the decade.
August 5, 2016 Bristol-Myers' Opdivo fails lung cancer trial; shares plunge Bristol-Myers Squibb Co said its blockbuster immunotherapy, Opdivo, failed to slow progression of symptoms in previously untreated patients with advanced lung cancer in a late-stage study, a major setback expected to benefit Merck & Co's rival medicine.